» Authors » Elizabeth Hernandez

Elizabeth Hernandez

Explore the profile of Elizabeth Hernandez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 856
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karpouzas G, Papotti B, Ormseth S, Palumbo M, Hernandez E, Adorni M, et al.
RMD Open . 2024 Dec; 10(4. PMID: 39719397
Objective: Excess cholesterol loading on arterial macrophages is linked to foam cell formation, atherosclerosis and cardiovascular risk in rheumatoid arthritis (RA). However, the effect of changes in cholesterol loading on...
2.
Gottesman S, Xiao K, Nguyen H, Hernandez E, Saweris E, Jaganathan P, et al.
Clin Transl Gastroenterol . 2024 Dec; PMID: 39718220
Background: Because biologic and small molecule therapy is expensive, payors have mandated pre-authorizations for these medications, often resulting in a lengthy approval process. The aims of this study are to...
3.
Brewster A, Hernandez E, Knox M, Rubio K, Sachdeva I
Health Serv Res . 2024 Nov; PMID: 39557585
Objective: To test quantitative process measures characterizing the work of social needs case managers as they assisted patients with diverse health-related needs-spanning both medical and social domains. Study Setting And...
4.
Kao W, Liao L, Chen Y, Lo U, Pong R, Hernandez E, et al.
Cell Death Dis . 2024 Sep; 15(9):678. PMID: 39284838
SPHK1 (sphingosine kinase type 1) is characterized as a rate-limiting enzyme in sphingolipid metabolism to phosphorylate sphingosine into sphingosine-1-phosphate (S1P) that can bind to S1P receptors (S1PRs) to initiate several...
5.
Arnett E, Pahari S, Leopold Wager C, Hernandez E, Bonifacio J, Lumbreras M, et al.
Biomed Pharmacother . 2023 Oct; 168:115738. PMID: 37864894
Tuberculosis (TB) accounts for 1.6 million deaths annually and over 25% of deaths due to antimicrobial resistance. Mycobacterium tuberculosis (M.tb) drives MCL-1 expression (family member of anti-apoptotic BCL-2 proteins) to...
6.
Karpouzas G, Papotti B, Ormseth S, Palumbo M, Hernandez E, Adorni M, et al.
J Transl Autoimmun . 2023 Jul; 7:100209. PMID: 37520890
Objectives: High-density lipoprotein (HDL) removes cholesterol from cells in atherosclerotic lesions, a function known as cholesterol efflux capacity (CEC). ATP-binding-cassette A1 (ABCA1) membrane transporter starts cholesterol transfer from macrophages to...
7.
Karpouzas G, Papotti B, Ormseth S, Palumbo M, Hernandez E, Adorni M, et al.
J Transl Autoimmun . 2023 Jul; 7:100206. PMID: 37484708
Objectives: Cholesterol efflux capacity (CEC) is the main antiatherogenic function of high-density lipoprotein (HDL). ATP-binding-cassette A1 (ABCA1) membrane transporter initiates cholesterol export from arterial macrophages to pre-β HDL particles fostering...
8.
Karpouzas G, Papotti B, Ormseth S, Palumbo M, Hernandez E, Adorni M, et al.
J Autoimmun . 2023 Mar; 136:103029. PMID: 36996698
Objectives: Cholesterol efflux capacity (CEC) measures the ability of high-density lipoprotein (HDL) to remove cholesterol from macrophages and reduce the lipid content of atherosclerotic plaques. CEC inversely associated with cardiovascular...
9.
Gonzalez P, Debnath S, Chen Y, Hernandez E, Jha P, Dakanali M, et al.
Pharmaceutics . 2023 Feb; 15(2). PMID: 36839802
After androgen deprivation therapy, a significant number of prostate cancer cases progress with a therapy-resistant neuroendocrine phenotype (NEPC). This represents a challenge for diagnosis and treatment. Based on our previously...
10.
Fleming M, Safaeinili N, Knox M, Hernandez E, Brewster A
Soc Sci Med . 2023 Feb; 320:115758. PMID: 36753994
Health care systems throughout the United States are initiating collaborations with social services agencies. These cross-sector collaborations aim to address patients' social needs-such as housing, food, income, and transportation-in health...